STERIS plc (STE) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $4.18B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m); Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-127.30M.
- 2026-03-31: Common Stock, Value, IssuedUSD $4.28B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD $-112.00M; Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD $-1.10M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-113.10M.
- 2025-12-31: Common Stock, Value, IssuedUSD $4.34B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m); Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-42.70M.
- 2025-09-30: Common Stock, Value, IssuedUSD $4.36B; Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of TaxUSD (m); Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-76.10M.
STERIS plc Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Preferred Stock, Value, Issued USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.18B | (m) | (m) | $-127.30M | $3.15B | $7.21B | $7.22B | (m) | (m) | (m) |
| 2026-03-31 | $4.28B | $-112.00M | $-1.10M | $-113.10M | $3.02B | $7.18B | $7.20B | 12 month · $2.40M | (m) | (m) |
| 2025-12-31 | $4.34B | (m) | (m) | $-42.70M | $2.86B | $7.15B | $7.17B | (m) | (m) | (m) |
| 2025-09-30 | $4.36B | (m) | (m) | $-76.10M | $2.73B | $7.01B | $7.02B | (m) | (m) | (m) |
| 2025-06-30 | $4.43B | (m) | (m) | $-70.50M | $2.60B | $6.96B | $6.97B | (m) | (m) | (m) |
| 2025-03-31 | $4.42B | $-291.80M | $-600.00K | $-292.30M | $2.48B | $6.60B | $6.62B | 12 month · $-26.70M | (m) | (m) |
| 2024-12-31 | $4.40B | (m) | (m) | $-374.25M | $2.39B | $6.42B | $6.43B | 3 month · $-114.00K 9 month · $26.83M | (m) | (m) |
| 2024-09-30 | $4.49B | (m) | (m) | $-165.84M | $2.27B | $6.59B | $6.61B | 3 month · $-77.00K 6 month · $26.94M | (m) | (m) |
| 2024-06-30 | $4.50B | (m) | (m) | $-323.07M | $2.18B | $6.35B | $6.37B | 3 month · $-73.00K | (m) | (m) |
| 2024-03-31 | $4.54B | $-327.90M | $-700.00K | $-328.70M | $2.09B | $6.30B | $6.32B | 12 month · $1.40M | (m) | (m) |
| 2023-12-31 | $4.53B | (m) | (m) | $-252.63M | $2.13B | $6.42B | $6.43B | 3 month · $-350.00K 9 month · $-985.00K | (m) | (m) |
| 2023-09-30 | $4.52B | (m) | (m) | $-386.74M | $2.05B | $6.18B | $6.19B | 3 month · $-275.00K 6 month · $-635.00K | (m) | (m) |
| 2023-06-30 | $4.50B | (m) | (m) | $-310.86M | $1.98B | $6.17B | $6.18B | 3 month · $-360.00K | (m) | (m) |
| 2023-03-31 | $4.49B | $-320.70M | $0.00 | $-320.70M | $1.91B | $6.08B | $6.09B | 12 month · $465.00K | (m) | (m) |
| 2022-12-31 | $4.63B | (m) | (m) | $-364.16M | $1.77B | $6.04B | $6.05B | 3 month · $-111.00K 9 month · $-348.00K | (m) | (m) |
| 2022-09-30 | $4.71B | (m) | (m) | $-598.15M | $1.70B | $5.80B | $5.81B | 3 month · $-122.00K 6 month · $-247.00K | (m) | (m) |
| 2022-06-30 | $4.74B | (m) | (m) | $-388.37M | $2.06B | $6.41B | $6.42B | 3 month · $-125.00K | (m) | (m) |
| 2022-03-31 | $4.74B | $-211.08M | $1.28M | $-209.81M | $2.00B | $6.53B | $6.54B | 12 month · $4.35M | (m) | (m) |
| 2021-12-31 | $4.76B | (m) | (m) | $-136.88M | $1.99B | $6.61B | $6.62B | 3 month · $-1.08M 9 month · $-3.27M | (m) | (m) |
| 2021-09-30 | $4.75B | (m) | (m) | $-105.73M | $1.89B | $6.54B | $6.54B | 3 month · $-1.09M 6 month · $-2.19M | (m) | (m) |
| 2021-06-30 | $4.74B | (m) | (m) | $-36.82M | $1.87B | $6.57B | $6.59B | 3 month · $-1.10M | (m) | (m) |
| 2021-03-31 | $2.00B | (m) | (m) | $-61.24M | $1.94B | $3.88B | $3.89B | 12 month · $3.33M | (m) | (m) |
| 2020-12-31 | $2.00B | (m) | (m) | $-2.39M | $1.87B | $3.87B | $3.89B | 3 month · $-833.00K 9 month · $-2.50M | (m) | (m) |
| 2020-09-30 | $1.99B | (m) | (m) | $-130.61M | $1.79B | $3.65B | $3.68B | 3 month · $-834.00K 6 month · $-1.67M | (m) | (m) |
| 2020-06-30 | $1.98B | (m) | (m) | $-208.35M | $1.70B | $3.47B | $3.50B | 3 month · $-828.00K | (m) | (m) |
| 2020-03-31 | $1.98B | (m) | (m) | $-235.46M | $1.66B | $3.41B | $3.42B | 12 month · $4.11M | $0.00 | (m) |
| 2019-12-31 | $1.99B | (m) | (m) | $-148.92M | $1.54B | $3.38B | $3.40B | 3 month · $-699.00K 9 month · $-2.09M | (m) | (m) |
| 2019-09-30 | $1.98B | (m) | (m) | $-225.72M | $1.47B | $3.23B | $3.24B | 3 month · $-695.00K 6 month · $-1.39M | (m) | (m) |
| 2019-06-30 | $2.00B | (m) | (m) | $-156.84M | $1.40B | $3.24B | $3.25B | 3 month · $-695.00K | (m) | (m) |
| 2019-03-31 | $2.00B | (m) | (m) | $-159.78M | $1.34B | $3.18B | $3.20B | 12 month · $1.38M | $0.00 | (m) |
| 2018-12-31 | (m) | (m) | (m) | $-167.03M | (m) | (m) | $3.11B | 3 month · $-563.00K 9 month · $-1.69M | $15.00K | (m) |
| 2018-09-30 | (m) | (m) | (m) | $-126.78M | (m) | (m) | $3.12B | 3 month · $-563.00K 6 month · $-1.13M | $15.00K | (m) |
| 2018-06-30 | (m) | (m) | (m) | $-121.10M | (m) | (m) | $3.10B | 3 month · $-563.00K | $15.00K | (m) |
| 2018-03-31 | $2.05B | (m) | (m) | $11.69M | $1.15B | $3.21B | $3.22B | 12 month · $2.01M | $15.00K | (m) |
| 2017-03-31 | (m) | (m) | (m) | $-240.70M | (m) | (m) | $2.81B | 12 month · $1.87M | $15.00K | 12 month · $530.00K |
| 2016-03-31 | (m) | (m) | (m) | $-68.16M | (m) | (m) | $3.04B | (m) | $15.00K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |